Jane Street Group, LLC Kymera Therapeutics, Inc. Transaction History

Jane Street Group, LLC

$445 Billion
Q3 2024

A detailed history of Jane Street Group, LLC transactions in Kymera Therapeutics, Inc. stock. As of the latest transaction made, Jane Street Group, LLC holds 88,474 shares of KYMR stock, worth $3.6 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

88,474

Previous 90,128 1.84%

Holding current value

$3.6 Million

Previous $2.69 Million 55.65%

% of portfolio

0.0%

Previous 0.0%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$30.16 - $52.4 $49,884 - $86,669	-1,654 Reduced 1.84%	88,474 $4.19 Million
Q2 2024 Aug 14, 2024	BUY	$29.85 - $39.42 $1.47 Million - $1.94 Million	49,119 Added 119.78%	90,128 $2.69 Million
Q1 2024 May 15, 2024	SELL	$22.9 - $43.57 $3.55 Million - $6.75 Million	-154,958 Reduced 79.07%	41,009 $1.65 Million
Q4 2023 Feb 14, 2024	BUY	$10.97 - $26.84 $1.06 Million - $2.6 Million	96,915 Added 97.84%	195,967 $4.99 Million
Q3 2023 Nov 14, 2023	SELL	$13.9 - $23.88 $508,350 - $873,339	-36,572 Reduced 26.97%	99,052 $1.38 Million
Q2 2023 Aug 14, 2023	BUY	$22.4 - $34.92 $1.59 Million - $2.47 Million	70,850 Added 109.38%	135,624 $3.12 Million
Q1 2023 May 15, 2023	SELL	$24.84 - $38.75 $129,739 - $202,391	-5,223 Reduced 7.46%	64,774 $1.92 Million
Q4 2022 Feb 14, 2023	BUY	$19.57 - $30.92 $181,472 - $286,721	9,273 Added 15.27%	69,997 $1.75 Million
Q3 2022 Nov 14, 2022	BUY	$20.91 - $34.27 $1.27 Million - $2.08 Million	60,724 New	60,724 $1.32 Million
Q2 2022 Aug 16, 2022	SELL	$14.13 - $42.55 $190,331 - $573,148	-13,470 Closed	0 $0
Q1 2022 May 17, 2022	BUY	$35.3 - $64.68 $235,309 - $431,156	6,666 Added 97.97%	13,470 $570,000
Q4 2021 Feb 15, 2022	BUY	$49.91 - $65.56 $152,574 - $200,416	3,057 Added 81.59%	6,804 $432,000
Q3 2021 Nov 16, 2021	BUY	$47.8 - $66.66 $179,106 - $249,775	3,747 New	3,747 $220,000
Q2 2021 Aug 16, 2021	SELL	$31.08 - $51.95 $1.26 Million - $2.1 Million	-40,394 Closed	0 $0
Q1 2021 May 18, 2021	BUY	$35.64 - $85.46 $1.32 Million - $3.16 Million	36,931 Added 1066.45%	40,394 $1.57 Million
Q4 2020 Feb 17, 2021	BUY	$28.07 - $87.83 $97,206 - $304,155	3,463 New	3,463 $215,000

Others Institutions Holding KYMR

# of Institutions

184

Shares Held

64.4M

Call Options Held

50.6K

Put Options Held

81.7K

View Full List

About Kymera Therapeutics, Inc.

Ticker KYMR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 54,705,800
Market Cap $2.22B
Description
Kymera Therapeutics, Inc., a biopharmaceutical company, focuses on discovering and developing novel small molecule therapeutics that selectively degrade disease-causing proteins by harnessing the body's own natural protein degradation system. It engages in developing IRAK4 program, which is in Phase I clinical trial for the treatment of immunolo...

More about KYMR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.

Account

Jane Street Group, LLC Kymera Therapeutics, Inc. Transaction History